Abstract 13170: Mechanical Thrombectomy or Bridging Therapy for Anterior Circulation Large Vessel Occlusion Strokes?

Gabriela Trifan,Jose Biller,Fernando Testai,Gabriela TrifanJose BillerFernando TestaiUniv of Ilinois at Chicago,Chicago,ILLOYOLA UNIV MED CTR,Maywood,ILUNIVERSITY OF ILLINOIS AT CHIC,Chicago,IL
DOI: https://doi.org/10.1161/circ.144.suppl_1.13170
IF: 37.8
2021-11-10
Circulation
Abstract:Circulation, Volume 144, Issue Suppl_1, Page A13170-A13170, November 16, 2021. Introduction:The superiority of intravenous thrombolysis plus mechanical thrombectomy in combination, also known as bridging therapy (BT), relative to mechanical thrombectomy (MT) alone in large vessel occlusion (LVO) stroke has not been established.Hypothesis:BT may have similar efficacy an safety profiles as MT for anterior circulation LVO.Methods:A systematic search of biomedical literature databases was performed up to March 2021, to identify prospective and retrospective studies that reported the rates for functional independence (defined as modified Rankin Scale 0-2) and mortality at 90 days, in-hospital symptomatic hemorrhage (sICH), and successful recanalization rates for MT and BT. Effect size was represented by odds ratio (OR) and analysis was done using random effects meta-analyses. Heterogeneity was assessed by I2and Cochrane's Q statistics.Results:Overall, 35 studies with 11,332 patients were included in the analysis. Mean age ± standard deviation for BT and MT was 69±12 and 70±12 years, respectively. BT group had 28% higher odds for functional independence (OR=1.28, 95% CI 1.13-1.46, I2=53%), 33% higher odds of successful reperfusion (OR=1.33, 95% CI=1.13-1.56, I2=43%) and a 31% decrease in odds for mortality (OR=0.69, 95% CI 0.59-0.81, I2=49%) compared with MT. The sICH prevalence was similar between groups (OR=1.03, 95% CI=0.87-1.22, I2=0%). When only RCTs with intention-to-treat analysis comparing BT to MT were included in the analysis (n=1,633), there were no differences in functional independence (OR=0.99, 95% CI=0.81-1.20, I2=0%), successful reperfusion (OR=1.33, 95% CI=0.95-1.87, I2=0%), sICH (OR=1.23, 95% CI=0.82-1.83, I2=0%) or mortality (OR=0.94, 95% CI=0.72-1.21, I2=0%) between the groups.Conclusions:The odds for functional independence, successful reperfusion and mortality favored the use of BT over MT. The study had medium heterogeneity and low quality of the evidence. However, when the analysis was restricted to RCTs intention to treat analyses, BT and MT had similar efficacy and safety outcomes, with no heterogeneity.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?